The present invention relates to a series of novel silicone phosphate esters which mitigate eye and skin irritation when used in synergistic combinations with fatty alcohol sulfates and fatty alcohol ether sulfates. These materials form complexes which have surprisingly low irritation properties.

Patent
   5859161
Priority
Dec 06 1993
Filed
Dec 06 1993
Issued
Jan 12 1999
Expiry
Jan 12 2016
Assg.orig
Entity
Large
4
5
EXPIRED
1. A process for the mitigating of irritation which comprises application to the skin of an effective irritation mitigating amount of a complex of the following formula; ##STR6## wherein R is ##STR7## a is an integer from 0 to 200; b is an integer from 0 to 200;
c is an integer from 1 to 200;
R1 is CH3 ;
n is a n integer from 0 to 10;.
R2 is --(CH2)3 --(OCH2 CH2)x --(OCH2 CH(CH3))y --(OCH2 CH2)Z --OH
x, y and z are integers and are independently selected from 0 to 20;
e and f range from 1 to 2 with the proviso that e+f=3;
M is selected from H, Na, K, Li or NH4;
R' is alkyl having from 10 to 20 carbon atoms;
q is a n integer ranging from 0 to 6.
2. A process of claim 1 wherein the effective irritation mitigating amount ranges from 0.01 to 20.0%, the % by weight is based upon total composition.
3. A process of claim 1 wherein q is 0 to 3.
4. A process of claim 1 wherein R' is alkyl having from 12 to 18 carbon atoms.
5. A process of claim 1 wherein R' is alkyl having 12 carbon atoms.
6. A process of claim 1 wherein R' is alkyl having 14 carbon atoms.
7. A process of claim 1 wherein R' is alkyl having 16 carbon atoms.
8. A process of claim 1 wherein R' is alkyl having 18 carbon atoms.
9. A process of claim 1 wherein M is Na.

(1) Field of Invention

The present invention relates to a series of novel silicone phosphate esters which mitigate eye and skin irritation when used in synergistic combinations with fatty alcohol sulfates and fatty alcohol ether sulfates. The compounds useful in to form synergistic combinations with fatty alcohol sulfates and fatty alcohol ether sulfates are the topic of U.S. Pat. No. 5,070,171 issued to O'Lenick, Jr. and U.S. Pat. No. 5,149,762 likewise issued to O'Lenick, Jr. which are incorporated herein by reference. These compounds are referred to in this specification as silicone phosphate esters. They are items of commerce and are manufactured by Siltech Inc. of Norcross Ga., to whom the above patents are assigned.

The compounds useful in preparing the synergistic blends of the present invention are fatty alcohol sulfates or fatty alcohol ether sulfates and silicone phosphate esters. The silicone phosphate esters are items of commerce and are prepared by the phosphation of a pendant hydroxyl group which is present on a silicone polymer.

We have surprisingly learned that if the silicone phosphate esters described in the above mentioned patents are mixed with fatty alcohol sulfates or fatty alcohol ether sulfates prior to contact with the eye and skin that the irritation values of the mixture are reduced by a factor of three. Application of the silicone phosphate ester to the skin or eye either before or immediately after the application of the fatty alcohol sulfate or fatty alcohol ether sulfate does not appreciably reduce the irritation values encountered. This is strong evidence for the formation of a complex which provides the protection. Generally, complexes form when anionic and cationic compounds are mixed. This is because of the opposite charges on the molecules. Generally, these complexes lose their surfactant properties such as foam and wetting. These complexes also do not mitigate irritation. Surprisingly, we have learned that there is a complex formed between the anionic fatty alcohol sulfate or fatty alcohol ether sulfate and the anionic silicone phosphate ester which mitigates irritation.

(2) Object of the Invention

It is the object of the present invention to provide a complex which mitigates irritation of fatty alcohol sulfates or fatty alcohol ether sulfates to the eyes and skin by incorporating a series of novel phosphated silicone polymers. The ratio of phosphate to sulfate can range from 1:1 to 0.01 to 1.

It is another objective of the current invention to provide a process for treating the hair and skin with the complex between the fatty alcohol sulfate or ether sulfate and the phosphated silicone polymer. The process comprises (1) formation of the complex by mixing together silicone phosphate ester and fatty alcohol sulfate or fatty alcohol ether sulfate and silicone phosphate ester, (2) contacting the hair or skin with an effective cleansing amount of the complex and (3) removing excess complex by rinsing with water. The ratio of phosphate to sulfate can range from 1:1 to 0.01 to 1.

(3) Description of the Arts and Practices

Fatty alcohol sulfates and fatty alcohol ether sulfates are a class of anionic detergents which are used very commonly in shampoo, skin cleanser and other applications which require detergency properties. These materials while outstanding detergents are quite irritating to skin and eyes. This is due in part to the fact that these materials de-fat the skin and eyes. That is they remove the naturally occurring fatty materials found in the normal hair and skin and leave the skin or eyes in a clean albeit irritated state.

The inclusion of ethylene oxide into the sulfate has a marginal effect upon irritation, reducing it somewhat. This reduction is obtained at the expense of cleansing properties. It was not until the present invention that it was realized that formation of a fatty alcohol sulfate or fatty alcohol ether sulfate and silicone phosphate ester complex effectively reduced irritation and did not adversely affect the performance of the detergent properties of the sulfate.

U.S. Pat. No. 5,070,171 issued to O'Lenick, Jr. and U.S. Pat. No. 5,149,762 likewise issued to O'Lenick, Jr. disclose the technology used to prepare the silicone phosphate esters useful as one ingredient in preparing the complex of the present invention.

PAC Summary of the Invention

The present invention relates the formation of a complex which mitigates the irritation of fatty alcohol sulfates or fatty alcohol ether sulfates without adversely affecting the surfactant properties of the fatty sulfates. The complex is prepared by mixing fatty alcohol sulfates or fatty alcohol ether sulfates with silicone phosphate esters. These complexes exhibit the same surfactant properties as the fatty alcohol sulfate or fatty alcohol ether sulfate, but surprisingly have the eye and skin irritation reduced by 3 to 5 times, when tested using standardized eye and skin irritation studies.

The complex of the invention is represented by the following formula; ##STR1## wherein R is ##STR2## a is an integer from 0 to 200; b is an integer from 0 to 200;

c is an integer from 1 to 200;

R1 is CH3 ;

n is an integer from 0 to 10;

R2 is --(CH2)3 --(OCH2 CH2)x --(OCH2 CH(CH3))y --(OCH2 CH2)Z --OH;

x, y and z are integers and are independently selected from 0 to 20;

e and f range from 1 to 2 with the proviso that e+f=3;

M is selected from H, Na, K, Li or NH4 ;

R' is alkyl having from 10 to 20 carbon atoms;

q is an integer ranging from 0 to 6.

The complexes of the present invention are prepared by mixing together the silicone phosphate ester and the fatty alcohol sulfate or fatty alcohol ether sulfate in aqueous solution ranging from 30 to 90 percent water. The ratio of phosphate to sulfate can range from 1:1 to 0.01 to 1.

The complex is applied to the skin or eye and the irritation is compared to that of the fatty alcohol sulfate or fatty alcohol ether sulfate alone.

As a control the phosphate ester was applied to the skin before addition of the fatty alcohol sulfate or fatty alcohol ether sulfate to see if there was any mitigation in irritation. There was no mitigation using this procedure.

As another control the fatty alcohol sulfate or fatty alcohol ether sulfate was applied to the skin immediately before addition of the silicone phosphate ester to see if there was any mitigation in irritation. There was no mitigation using this procedure.

These findings confirm the existence of a irritation mitigating complex which needs to be formed prior to application on the eye or skin.

The silicone phosphate esters used in the preparation of the complexes of the present invention are prepared by reaction of a hydroxyl containing silicone polymer with a suitable phosphating reagent.

One method of placing the reactive hydroxyl containing silicone polymer is to react silanic hydrogen containing polymer with allyl alcohol or allyl alcohol alkoxylate monomer.

Procedures for this reaction are well known to those skilled in the art. U.S. Pat. No. 4,083,856 describe suitable processes.

PAC Vinyl Intermediate Compounds

Compounds of this class are prepared by alkoxylation of allyl alcohol using methods well known to those skilled in the art. The following are some of the many compounds which can be used to make the products of this invention.

______________________________________
CH2 --CH--CH2 --O--(CH2 --CH2 --O)x --(CH2
--CH(CH3)--O)y --(CH2 --CH2 --O)z --H
Molecular
Designation x y z Weight
______________________________________
A 3 0 0 189
B 9 27 3 2,178
C 11 3 0 718
D 0 0 0 57
E 20 20 20 2,940
F 20 0 0 880
G 10 10 10 1,470
______________________________________

Silicone intermediates of the type used to make the compounds of this invention are well known to those skilled in the art. International Publication (Silicone Alkylene Oxide Copolymers As Foam Control Agents) WO 86/0541 by Paul Austin (Sep. 25, 1986) p. 16 (examples 1 to 6) teaches how to make the following intermediates, and is incorporated herein by reference.

______________________________________
Silanic Hydrogen Containing Compounds
##STR3##
Average
Equivalent
Austin Group Molecular
Molecular
Example Example Designation Weight Weight
______________________________________
1 1 MD 20 D' 3.2 M
1,850 551
2 4 MD 160 D' 5 M
24,158 4,831
3 6 MD 20 D' 10 M
2,258 225
______________________________________

The hydrosilation reaction used to make the compounds of this invention are well known to those skilled in the art. Reference; International Publication (Silicone Alkylene Oxide Copolymers As foam Control Agents) WO 86/0541 by Paul Austin (Sep. 25, 1986) p. 19.

To a liter three necked round bottom flask fitted with a mechanical agitator, thermometer with a Therm-o-watch temperature regulator, nitrogen sparge tube vented reflux condenser and heating mantle is added 189.0 grams of Vinyl Intermediate Example # A. Next add 225 grams of Silanic Hydrogen Containing Compound Example #3 and 3,000 grams of toluene. Heat to 115°C to remove azeotropically remove any water 200 ml of toluene. The temperature is reduced to 85°C and ml of 3% H 2 PtCl 6 in ethanol is added. Light is then excluded from the flask by covering it with a black cloth. An exotherm is noted to about 95°C, while the contents are stirred about 2 hours. During this time silanic hydrogen concentration drops to nil. Cool to 65°C and slowly add 60 g of sodium bicarbonate allow to mix overnight and filter through a 4 micron pad. Distill off any toluene at 100°C and 1 torr.

The above procedure is repeated, only this time replacing both silanic hydrogen compound #3 with the specified number of ms of the specified silanic hydrogen compound and the vinyl intermediate example A with the specified number of grams of the specified vinyl intermediate.

______________________________________
Vinyl Intermediate
Silanic Hydrogen Compound
Example Example Grams Example Grams
______________________________________
4 A 189.0 1 551.0
5 B 2,178.0 2 4,831.0
6 C 718.0 3 225.0
7 D 57.0 1 551.0
8 E 2,940.0 2 4,831.0
9 F 880.0 3 225.0
10 G 1,470.0 1 551.0
______________________________________
PAC Phosphating Agents

Polyphosphoric Acid (PPA) is 115% phosphoric acid. When used as a phosphating agent in gives more mono ester than the phosphorus pentoxide.

Phosphorus pentoxide is P2 O5. It is more aggressive in phosphation and results in more diester.

The silicone phosphates useful as raw materials for the practice of this invention can be prepared by reacting the hydroxyl containing silicone polymer with a suitable phosphating agent. Preferred phosphating reagents are polyphosphoric acid and phosphorus pentoxide.

The preparation of the novel silicone phosphates of this invention from the hydroxy silicone compounds can be illustrated by the following reaction in which R is the hydroxy silicone compound. ##STR4##

It will be understood by the above reaction that the product of phosphation, using polyphosphoric acid or phosphorus pentoxide give a mixture of mono and di ester.

The following examples further illustrate the objects and advantages of this invention, though it should be understood that the various reactants and amounts thereof, reaction conditions, and other details are merely illustrative and should not be construed to unduly limit this invention.

The specified amount of hydroxy silicone compound (Examples 4-10) is added to a suitable reaction vessel. The specified amount of either polyphosphoric acid or phosphorus pentoxide is charged to under good agitation over a 2 hr. period. The exothermic reaction raises the temperature of the period. The exothermic reaction raises the temperature of the mixture to about 70°C After 1 hour slowly raise the temperature to 100°C and hold 2-4 hours.

______________________________________
Hydroxy Silicone
Polyphosphoric Acid
Example Example Grams Grams
______________________________________
11 4 740.0 56.5
12 5 7009.0 56.5
13 6 943.0 56.5
14 7 608.0 56.5
15 8 7771.0 56.5
16 9 1105.0 56.5
17 10 2021.0 56.5
______________________________________
______________________________________
Phosphorus Pentoxide
Hydroxy Silicone
Phosphorus Pentoxide
Example Example Grams Grams
______________________________________
18 11 798.0 36.0
19 12 7067.0 36.0
20 13 1001.0 36.0
21 14 666.0 36.0
22 15 7829.0 36.0
23 16 1163.0 36.0
24 17 2079.0 36.0
______________________________________

The compounds of examples 11-24 are neutralized to pH 7 with 20% aqueous base. The following bases are used; NaOH, KOH, LiOH, NH 4 OH.

______________________________________
Phosphated Silicone Base
Example Example Type
______________________________________
25 11 KOH
26 12 NaOH
27 13 LiOH
28 14 NH4OH
29 15 KOH
30 16 NaOH
31 17 KOH
32 19 NaOH
33 19 KOH
34 20 NaOH
35 21 KOH
36 22 NaOH
37 23 KOH
38 24 NaOH
______________________________________

These materials are items of commerce available from a variety of sources including Henkel Corporation and Stepan.

______________________________________
Example R' q N Description
______________________________________
39 C10 H21 0 K Potassium Decyl
Sulfate
40 C12 H25 0 Na Sodium Lauryl
Sulfate
41 C14 H29 0 Li Lithium Myristyl
Sulfate
42 C16 H33 0 NH4 Ammonium Cetyl
Sulfate
43 C18 H37 0 Na Sodium Stearyl
Sulfate
44 C10 H21 3 K Potassium Deceth
(3) Sulfate
45 C12 H25 3 Li Lithium Laureth
(3) Sulfate
46 C14 H29 3 NH4 Ammonium Myreth
(3) Sulfate
47 C16 H33 6 Na Sodium Ceteth
(6) Sulfate
48 C18 H37 6 Na Sodium Steareth
(6) Sulfate
49 C20 H41 6 K Potassium Beheneth
(6) Sulfate
50 C12 H25 4 Na Sodium Laureth
(4) Sulfate
______________________________________

The number in parenthesis is the value of "q". Therefore Sodium Laureth (4) Sulfate is ##STR5##

The complex between the fatty alcohol sulfate or fatty alcohol ether sulfate and silicone phosophate ester is obtained by mixing the two components in aqueous solution. The preferred concentration of water is between 50 and 80% by weight.

100.0 grams of fatty alcohol sulfate (example 39) is added to 200.0 grams of water. Next, 1.0 grams of silicone phosphate (example 25) is added under good agitation. The resulting complex is found to have very low eye and skin irritation compared to the fatty alcohol sulfate alone.

Example 51 is repeated, only this time substituting the specified type and amount of fatty alcohol sulfate or fatty alcohol ether sulfate for example 39 and substituting the specified type and amount of silicone phosaphate ester for example 25.

______________________________________
Fatty Sulfate Silicone Phosphate
Example Example Amount Example
Amount
______________________________________
52 40 100.0 26 100.0
53 41 100.0 27 50.0
54 42 100.0 28 25.0
55 43 100.0 29 1.0
56 44 100.0 30 100.0
57 45 100.0 31 75.0
58 46 100.0 32 100.0
59 47 100.0 33 50.0
60 48 100.0 34 5.0
61 49 100.0 35 100.0
62 50 100.0 36 75.0
63 39 100.0 37 50.0
64 40 100.0 38 10.0
______________________________________

Primary Skin Irritation was run using the protocol outlined in FHSLA 16 C.F.R. 1500.41

______________________________________
Test Example Rating Rating
______________________________________
40 2.7 Moderate Primary Irritant
______________________________________

Sodium Lauryl Sulfate is itself a moderate skin irritation.

______________________________________
Test Example Rating Rating
______________________________________
52 0.3 Non-primary Irritant
______________________________________

Sodium Lauryl Sulfate is itself a moderate skin irritation, has it's irritation reduced to non-irritating status by addition of silicone phosphate.

______________________________________
Test Example Rating Rating
______________________________________
64 0.4 Non-primary Irritant
______________________________________

Sodium Lauryl Sulfate is itself a moderate skin irritation, has it's irritation reduced to non-irritating status by addition of silicone phosphate.

The skin was pretreated with silicone phosphate example 38 followed by treatment with fatty sulfate example 40. The resulting skin irritation data was 2.3. The pretreatment with silicone phosphate is not an effective irritation mitigant.

The skin was pretreated with fatty sulfate example 40 followed by treatment with silicone phosphate example 38. The resulting skin irritation data was 2.6. The post treatment with silicone phosphate is not an effective irritation mitigant.

Unexpectedly, only when the two are combined in a complex is the desired mitigation of skin irritation observed.

The same reduction in irritation values are observed in eye irritation studies. Again, in order to be effective the complex must be applied. The effect is not observed when the two are applied separately, regardless of the order of application.

O'Lenick, Jr., Anthony J., Imperante, John

Patent Priority Assignee Title
7122174, Sep 30 2002 L OREAL S A Compositions comprising at least one silicone compound and at least one amine compound, and methods for using the same
9012547, Nov 09 2010 Dow Corning Corporation Hydrosilylation cured silicone resins plasticized by organophosphorous compounds
9308668, Apr 18 2011 Momentive Performance Materials GmbH Functionalized polyorganosiloxanes or silanes for the treatment of lignocellulosic materials
9931760, Apr 18 2011 Momentive Performance Materials GmbH Functionalized polyorganosiloxanes or silanes for the treatment of lignocellulosic materials
Patent Priority Assignee Title
3961044, Feb 01 1967 Cincinnati Milacron, Inc. Skin protective compositions
4960845, Nov 08 1989 Siltech Corporation Sulfated silicone polymers
5070171, Jun 27 1990 SILTECH CORP Phosphated silicone polymers
5091493, Jun 27 1990 SILTECH CORP Silicone phosphobetaines
5149762, Nov 08 1988 Mitsubishi Rayon Company Ltd. Process for preparation of silicon-modified thermoplastic resin
/////
Executed onAssignorAssigneeConveyanceFrameReelDoc
Dec 06 1993Phoenix Chemical(assignment on the face of the patent)
Dec 06 1993Lambent Technologics Inc(assignment on the face of the patent)
Feb 15 2002O LENICK, ANTHONY J LAMBENT TECHNOLOGIES CORP , C O PETROFERM INC,ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0142350532 pdf
Jun 30 2005NOVEON IP HOLDINGS CORP NOVEON, INC MERGER SEE DOCUMENT FOR DETAILS 0179570694 pdf
Jun 04 2007NOVEON, INC LUBRIZOL ADVANCED MATERIALS, INCCHANGE OF NAME SEE DOCUMENT FOR DETAILS 0213160211 pdf
Date Maintenance Fee Events
Jun 28 2002M183: Payment of Maintenance Fee, 4th Year, Large Entity.
Aug 05 2002R283: Refund - Payment of Maintenance Fee, 4th Yr, Small Entity.
Aug 05 2002STOL: Pat Hldr no Longer Claims Small Ent Stat
Jun 26 2006M1552: Payment of Maintenance Fee, 8th Year, Large Entity.
Aug 16 2010REM: Maintenance Fee Reminder Mailed.
Jan 12 2011EXP: Patent Expired for Failure to Pay Maintenance Fees.


Date Maintenance Schedule
Jan 12 20024 years fee payment window open
Jul 12 20026 months grace period start (w surcharge)
Jan 12 2003patent expiry (for year 4)
Jan 12 20052 years to revive unintentionally abandoned end. (for year 4)
Jan 12 20068 years fee payment window open
Jul 12 20066 months grace period start (w surcharge)
Jan 12 2007patent expiry (for year 8)
Jan 12 20092 years to revive unintentionally abandoned end. (for year 8)
Jan 12 201012 years fee payment window open
Jul 12 20106 months grace period start (w surcharge)
Jan 12 2011patent expiry (for year 12)
Jan 12 20132 years to revive unintentionally abandoned end. (for year 12)